Author

B. W. Kristensen

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 5 Bioengineering· 1 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 6 Approach:experimental assay· 6 Organism:human· 5 Assay:bulk RNA-seq· 3 Research Focus:differential expression· 3 Research Focus:cancer & tumor microenvironment· 2 Organism:mouse· 2 Assay:proteomics· 2

Frequent Co-Authors

D. J. Silver· 3 shared D. Bayik· 2 shared J. D. Lathia· 2 shared J. Lathia· 2 shared M. A. Vogelbaum· 2 shared M. D. Sorensen· 2 shared M. M. Grabowski· 2 shared M. McGraw· 2 shared

Activity by Year

2018-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 35 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersCancer Biology

D. J. Silver

Mutual co-authors in cluster

Author profile →

7 papers

Recent·Most cited

Refining Spatial Proteomics by Mass Spectrometry: An Efficient Workflow Tailored for Archival Tissue

R. Daucke, C. V. Rift, N. S. Bager, K. Saxena, P. R. Koffeldt, J. Woessmann, V. Petrosius, E. S. Rugiu, B. W. Kristensen, P. Klausen, E. M. Schoof

This paper develops an efficient workflow for spatial proteomics on FFPE tissue using low-input material, showing that EpCAM staining improves protein identification compared to H&E staining.

BMC Methods · Apr 22, 2026Peer-reviewedBioengineering

Glioblastoma cells imitate neuronal excitability in humans

T. Tong, J. D. Hendriksen, K. J. Elbaek, A. Ozsvar, J. T. Eschen, F. G. Rodriguez-Gonzalez, I. D. Pusat, E. L. Christensen, M. Rahbaek, K. P. Frederiksen, S. O. S. Cortnum, A. K. Sindby, K. Meier, N. Mikic, J. C. H. Sorensen, , A. R. Korshoj

This study identifies that glioblastoma cells in the tumor's invasive leading edge exhibit electrophysiological properties similar to neurons, including action potentials, and show reduced proliferation signaling.

bioRxiv · Jan 8, 2024 · PreprintCancer Biology

Insight into spatial intratumoral genomic evolution in glioblastoma

A. Anand, J. K. Petersen, L. v. B. Andersen, M. Burton, M. J. Larsen, C. B. Pedersen, F. R. Poulsen, P. Grupe, T. A. Kruse, M. Thomassen, B. W. Kristensen

This study investigates spatial genomic evolution in glioblastoma by comparing hypometabolic and hypermetabolic lesions using genomic and transcriptomic analyses.

bioRxiv · Sep 11, 2023 · PreprintCancer Biology

Tumor cell-intrinsic HFE drives glioblastoma growth

K. M. Troike, D. J. Silver, P. K. Ghosh, E. E. Mulkearns-Hubert, C. G. Hubert, J. R. Connor, P. L. Fox, B. W. Kristensen, J. Lathia

This study shows that HFE promotes glioblastoma growth by regulating iron homeostasis and oxidative stress, with HFE loss inducing apoptosis and extending survival.

bioRxiv · Apr 13, 2022 · PreprintCancer Biology

Myeloid-derived suppressor cell subsets drive glioblastoma growth in a sex-specific manner

D. Bayik, Y. Zhou, C. Park, C. Hong, D. Vail, D. J. Silver, A. J. Lauko, G. A. Roversi, D. C. Watson, A. Lo, T. J. Alban, M. McGraw, M. D. Sorensen, M. M. Grabowski, B. Otvos, , J. Lathia

This study identifies sex-specific roles of MDSC subsets in glioblastoma, showing mMDSCs drive growth in males and gMDSCs in females, with potential therapeutic targets.

bioRxiv · Feb 19, 2020Immunology

Asymmetric Division Promotes Therapeutic Resistance In Glioblastoma Stem Cells

M. Hitomi, A. P. Chumakova, D. J. Silver, A. M. Knudsen, W. D. Pontius, S. Murphy, N. Anand, B. W. Kristensen, J. D. Lathia

The paper shows that asymmetric division in glioblastoma stem cells generates daughter cells with enhanced therapeutic resistance and co-inherited growth factor receptors.

bioRxiv · Mar 6, 2019Cancer Biology

Global immune fingerprinting in glioblastoma reveals immune-suppression signatures associated with prognosis

T. J. Alban, A. G. Alvarado, M. D. Sorensen, D. Bayik, J. Volovetz, E. Serbinowski, E. Mulkearns-Hubert, M. Sinyuk, J. S. Hale, G. R. Onzi, M. McGraw, P. Huang, M. M. Grabowski, C. A. Wathen, T. Radivoyevitch, , J. D. Lathia

The paper identifies immune-suppression signatures in glioblastoma (GBM) patients, showing elevated myeloid-derived suppressor cells (MDSCs) linked to poor prognosis and reduced survival.

JCI Insight · Nov 2, 2018Peer-reviewedCancer Biology